A vs BIO
As of Sep 20, 2026, Agilent Technologies (A) scores 6.4/10 and Bio-Rad Laboratories (BIO) 7.4/10 on AlphaStocks' five-model composite, so BIO scores higher. A trades 28% above its model fair value.
A
AGILENT TECHNOLOGIES, INC.
6.4
Consider Buy
$156.46
BIO
BIO-RAD LABORATORIES, INC.
7.4
Consider Buy
$375.68
A vs BIO: Which is the Better Investment?
AGILENT TECHNOLOGIES, INC. (A) scores 6.4/10 while BIO-RAD LABORATORIES, INC. (BIO) scores 7.4/10 on AlphaStocks' composite model. BIO-RAD LABORATORIES, INC. has the higher composite rating of Consider Buy. On a P/E basis, BIO-RAD LABORATORIES, INC. trades at 13.5x, making it the more attractively priced of the two.
This comparison is algorithmically generated and is not financial advice.
| Metric | A | BIO |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 6.4/10 | 7.4/10▲ |
| Rating | Consider Buy | Consider Buy▲ |
| Price | $156.46 | $375.68 |
| P/E Ratio | 34.2 | 13.5▲ |
| ROE | 19.9%▲ | 9.7% |
| Market Cap | $44B | $10B |
| Fair Value | $122.19 | — |
| Dividend Yield | 0.7% | — |
| Sector Rank | #33 of 168 | #7 of 168▲ |
| Model Verdicts | ||
| Piotroski | Attractive | Attractive |
| Buffett | Attractive▲ | Neutral |
| Graham | Neutral | Attractive▲ |
| Lynch | Neutral | Attractive▲ |
| Greenblatt | Neutral | Strong▲ |
Related comparisons
A vs BIO: Which Stock Scores Higher?
AGILENT TECHNOLOGIES, INC. (A) and BIO-RAD LABORATORIES, INC. (BIO) are both in the Health Care sector. BIO currently leads with a composite score of 7.4/10 (Consider Buy) compared to A's 6.4/10 (Consider Buy).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer